MC1119A1 - Derives de l'isoquinoleine,leur preparation et medicaments contenant ces substances - Google Patents

Derives de l'isoquinoleine,leur preparation et medicaments contenant ces substances

Info

Publication number
MC1119A1
MC1119A1 MC761222A MC1222A MC1119A1 MC 1119 A1 MC1119 A1 MC 1119A1 MC 761222 A MC761222 A MC 761222A MC 1222 A MC1222 A MC 1222A MC 1119 A1 MC1119 A1 MC 1119A1
Authority
MC
Monaco
Prior art keywords
bis
dimethyl
dioxo
dioxa
tetrahydropapaverinium
Prior art date
Application number
MC761222A
Other languages
English (en)
French (fr)
Inventor
J Urwin
R Waich
N Dhar
J Stenlake
G Dewar
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26265501&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MC1119(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB4502876A external-priority patent/GB1579822A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC1119A1 publication Critical patent/MC1119A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/14—Preparation of carboxylic acid esters from carboxylic acid halides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MC761222A 1975-12-10 1976-12-09 Derives de l'isoquinoleine,leur preparation et medicaments contenant ces substances MC1119A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5058975 1975-12-10
GB4502876A GB1579822A (en) 1976-10-29 1976-10-29 Tetrahydroisoquinolinium muscle relaxants

Publications (1)

Publication Number Publication Date
MC1119A1 true MC1119A1 (fr) 1977-08-12

Family

ID=26265501

Family Applications (1)

Application Number Title Priority Date Filing Date
MC761222A MC1119A1 (fr) 1975-12-10 1976-12-09 Derives de l'isoquinoleine,leur preparation et medicaments contenant ces substances

Country Status (24)

Country Link
US (1) US4179507A (enExample)
JP (1) JPS6043342B2 (enExample)
AT (1) AT365579B (enExample)
AU (1) AU506657B2 (enExample)
CA (1) CA1075241A (enExample)
CH (1) CH625223A5 (enExample)
CY (1) CY1217A (enExample)
DD (1) DD128320A5 (enExample)
DE (1) DE2655883A1 (enExample)
DK (1) DK149751C (enExample)
FI (1) FI61485C (enExample)
FR (1) FR2334359A1 (enExample)
HK (1) HK35084A (enExample)
IE (1) IE44569B1 (enExample)
IL (1) IL51074A (enExample)
IT (1) IT1188908B (enExample)
KE (1) KE3361A (enExample)
LU (1) LU76355A1 (enExample)
MC (1) MC1119A1 (enExample)
MY (1) MY8500287A (enExample)
NL (1) NL178688C (enExample)
NZ (1) NZ182847A (enExample)
SE (1) SE434154B (enExample)
SU (1) SU718008A3 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235906A (en) 1978-07-21 1980-11-25 Massachusetts General Hospital Bis-isoquinolinium compounds, compositions and methods of use
CA1125287A (en) * 1978-07-21 1982-06-08 John J. Savarese Bis isoquinolinium compositions and methods of use
US4491665A (en) * 1979-10-19 1985-01-01 Burroughs Wellcome Co. Method of preparing isomers of bis isoquinolinium compounds
US4315935A (en) * 1980-04-14 1982-02-16 Smithkline Corporation N,N'-Bis[substituted-1,2,3,4-tetrahydroisoquinolinolyl]disulfonylimides and antiallergic compositions and method of use
US4317826A (en) * 1980-05-27 1982-03-02 Smithkline Corporation N,N'-Bis[substituted-1,2,3,4 tetrahydroisoquinolyl]disulfonylimides and antiallergic compositions and method of use
US4701460A (en) * 1980-12-17 1987-10-20 Burroughs Wellcome Co. Long duration neuromuscular blocking agents
GB8418303D0 (en) * 1984-07-18 1984-08-22 Wellcome Found Compounds
GB9015473D0 (en) 1990-07-13 1990-08-29 Wellcome Found Neuromuscular blocking agents
US5453510A (en) * 1990-07-13 1995-09-26 Burroughs Wellcome Co. Neuromuscular blocking agents
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
US5510355A (en) * 1994-09-06 1996-04-23 Bencherif; Merouane Depolarizing skeletal muscle relaxants
IT1277700B1 (it) * 1995-12-22 1997-11-11 Poli Ind Chimica Spa Processo di preparazione di 2-beta, 16-beta-diamino 3-alfa, 17-beta- diacilossi 5-alfaandrostani, bloccanti neuromuscolari a struttura
US5684154A (en) * 1996-02-16 1997-11-04 Abbott Laboratories Process for the preparation and isolation of atracurium besylate
MA26476A1 (fr) * 1997-03-25 2004-12-20 Cornell Res Foundation Inc Bloquants neuromusculaires a duree d' action ultra-courte
GB0204087D0 (en) * 2002-02-21 2002-04-10 Legislator 1563 Ltd Di-ester derivatives as short acting neuromuscular blockers
CN101588803B (zh) * 2006-12-06 2013-03-20 康乃尔研究基金会有限公司 中等持续时间神经肌肉阻断剂及其拮抗剂
AU2008222298A1 (en) * 2007-03-08 2008-09-12 Chemagis Ltd. (1R,1'R)-atracurium salts separation process
WO2008117271A1 (en) * 2007-03-26 2008-10-02 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
AU2008273724B2 (en) * 2007-05-01 2013-05-23 Chemagis Ltd. Process for Producing Cisatracurium and Associated Intermediates
BRPI0809893A2 (pt) * 2007-05-01 2014-09-30 Chemagis Ltd Processo para prepar um sal de (1r-cis) - [(3,4 - dimetoxifenil) metil] - 1, 2,3,4 - tetraidro - 6,7 - dimetoxi - 2 - metil - 2 - carboxietil - isoquinolínio"
AU2008264802A1 (en) * 2007-06-18 2008-12-24 Chemagis Ltd. (1R,1'R)-atracurium salts separation process
CN101337935B (zh) * 2007-07-06 2011-01-12 江苏恒瑞医药股份有限公司 一种用两相萃取法纯化苯磺酸阿曲库铵的方法
CN101337936B (zh) * 2007-07-06 2011-03-23 江苏恒瑞医药股份有限公司 一种用柱色谱法纯化苯磺酸阿曲库铵的方法
US20100256381A1 (en) * 2007-07-09 2010-10-07 Chemagis Ltd. Process for producing cisatracurium and associated intermediates
AU2008320380A1 (en) * 2007-10-29 2009-05-07 Chemagis Ltd. Novel R,R'-atracurium salts
AU2009241211A1 (en) * 2008-05-01 2009-11-05 Chemagis Ltd. Cisatracurium derivatives, preparation and uses thereof
US8592451B2 (en) 2009-03-17 2013-11-26 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
CA2758353C (en) * 2009-04-14 2017-06-06 Dean David Edney Process for the preparation of a biphenyl-2-ylcarbamic acid ester
US9220700B2 (en) 2009-08-19 2015-12-29 Cornell University Cysteine for physiological injection
EP2514754B1 (en) 2011-04-08 2013-08-21 King Saud University 6,7-dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical composition containing the same as neuromuscular blocker or skeletal muscle relaxant, and method for the preparation
CN102249998B (zh) * 2011-06-20 2013-09-25 浙江仙琚制药股份有限公司 一种制备顺苯磺酸阿曲库铵的方法
CN102898370A (zh) * 2012-11-11 2013-01-30 苏州二叶制药有限公司 注射用顺苯磺阿曲库铵
WO2018193463A1 (en) * 2017-04-21 2018-10-25 Neon Laboratories Limited An improved process for the preparation of tetrahydroisoquinoline compounds
CN114181147A (zh) * 2021-12-27 2022-03-15 上海药坦药物研究开发有限公司 一种苯磺阿曲库铵的处理方法
CN115850169B (zh) * 2022-10-17 2025-04-04 上海医药集团(本溪)北方药业有限公司 苯磺顺阿曲库铵杂质及其中间体的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
GB1125619A (en) * 1965-11-15 1968-08-28 Wellcome Found Derivatives of bis-isoquinolines

Also Published As

Publication number Publication date
CH625223A5 (enExample) 1981-09-15
FR2334359B1 (enExample) 1981-10-16
DE2655883A1 (de) 1977-06-23
LU76355A1 (enExample) 1977-06-24
AU506657B2 (en) 1980-01-17
FI61485C (fi) 1982-08-10
SU718008A3 (ru) 1980-02-25
DD128320A5 (de) 1977-11-09
DE2655883C2 (enExample) 1990-02-01
IT8048000A0 (it) 1980-02-25
IL51074A (en) 1980-05-30
FI61485B (fi) 1982-04-30
DK149751C (da) 1987-03-23
HK35084A (en) 1984-04-27
IE44569L (en) 1977-06-10
IT8048000A1 (it) 1981-08-25
NL178688C (nl) 1986-05-01
FI763543A7 (enExample) 1977-06-11
AU2037576A (en) 1978-06-15
CA1075241A (en) 1980-04-08
NL7613695A (nl) 1977-06-14
IT1188908B (it) 1988-01-28
AT365579B (de) 1982-01-25
ATA908476A (de) 1981-06-15
JPS6043342B2 (ja) 1985-09-27
CY1217A (en) 1984-04-06
DK553676A (da) 1977-06-11
KE3361A (en) 1984-02-17
US4179507A (en) 1979-12-18
IL51074A0 (en) 1977-02-28
SE7613824L (sv) 1977-06-11
MY8500287A (en) 1985-12-31
SE434154B (sv) 1984-07-09
NZ182847A (en) 1979-06-08
IE44569B1 (en) 1982-01-13
NL178688B (nl) 1985-12-02
DK149751B (da) 1986-09-22
JPS5277069A (en) 1977-06-29
FR2334359A1 (fr) 1977-07-08

Similar Documents

Publication Publication Date Title
MC1119A1 (fr) Derives de l'isoquinoleine,leur preparation et medicaments contenant ces substances
EP0486386A2 (fr) Nouveaux dérivés de la N-benzoyl proline, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
FR2546166A1 (fr) Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
BRPI0612138B1 (pt) compostos éter aminocicloexílicos e método para fazer os mesmos
EP0364350B1 (fr) Dérivés de méthyl-4[(phényl-4 pipérazinyl-1)-2 éthyl]-5 thiazole, leur procédé de préparation et les compositions pharmaceutiques en contenant
FR2510575A1 (fr) Nouveaux composes bicycliques, leur procede de preparation et composition pharmaceutique les renfermant
EP0037344B1 (fr) Amino-alcoxy pyrazoles, procédé pour leur préparation, et médicaments les contenant
KR970004912B1 (ko) 신규 2-카르보닐 치환 n,n'-디-(트리메톡시벤조일)피페라진, 이들의 제조방법 및 이들을 함유한 치료 조성물.
EP0173585B1 (fr) Médicaments à base de dérivés de la pipéridine, nouveaux dérivés de la pipéridine et leurs procédés de préparation
EP0082058B1 (fr) Ethers d'oximes de pyridyl-1 pentanone-3, leur procédé de préparation et leur utilisation comme médicament
EP0015171A1 (fr) Dérivés condensés de pyrrolidine ou de pipéridine, leur procédé de préparation et composition les contenant
EP0347305B1 (fr) [(Aryl-4-pipérazinyl-1)-2 éthoxy]-3 p-cymène, les dérivés ortho, méta, para monosubstitués ou disubstitués sur le noyau phényle dudit produit, le procédé de préparation desdits dérivés, et les médicaments contenant lesdits composés comme principe actif
EP0017523B1 (fr) Nouveaux dérivés du dithiépinno (1,4)(2,3-c)pyrrole, leur préparation et les médicaments qui les contiennent
MC586A1 (fr) Nouveaux dérivés du dioxanne 1.3 et leur préparation
EP0026168B1 (fr) Nouveaux dérivés de décahydroquinoléinol, leur procédé de préparation ainsi que leurs applications en thérapeutique
EP0982308B1 (fr) Dérivés de 8H-(2,3-b)-pyrrolizine-8-one, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0099822B1 (fr) Nouveaux 1-(2-carbalkoxy 4-(thiénylalkylamido)phénoxy) 3-amino 2-propanols, leur préparation et leurs applications en thérapeutique
FR2479814A1 (fr) Phenyl alcoxy propanolamines, leur preparation et leur application en tant que medicaments
EP0236151A1 (fr) Dioximes O-substituées symétriques de beta-dicéto-cycloalkylènes benzo-condensés, leurs procédés de préparation et leur application comme médicaments
EP0082059A1 (fr) Ethers d'oximes alpha-bêta insaturés, leur procédé de préparation et leur utilisation comme médicament
EP0127529A2 (fr) N-oxydes de dérivés aminocycliques, leur procédé de préparation et leur application en thérapeutique
FR2539412A1 (fr) Derives du 5-fluoruracile et leurs utilisations therapeutiques en tant qu'agents carcinostatiques
FR2479812A1 (fr) Cycloalcoyl propanol amines utiles comme medicaments et procede pour leur preparation
FR2530245A1 (fr) Nouveaux 1-(2-carbalkoxy 4-(thienyl-alkylamido)phenoxy) 3-amino 2-propanols, leur preparation et leurs applications en therapeutique
FR2504141A1 (fr) Nouveaux derives dioxazabicycliques, leur procede de preparation et leur application en therapeutique

Legal Events

Date Code Title Description
YP Annual fee paid